A 3D Human Liver Model of Nonalcoholic Steatohepatitis
Open Access
- 3 July 2020
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 8 (3), 1-12
- https://doi.org/10.14218/jcth.2020.00015
Abstract
Background and Aims: To better understand nonalcoholic steatohepatitis (NASH) disease progression and to evaluate drug targets and compound activity, we undertook the development of an in vitro 3D model to mimic liver architecture and the NASH environment.Keywords
This publication has 51 references indexed in Scilit:
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADMEArchives of Toxicology, 2013
- Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α ProductionJournal of Biological Chemistry, 2012
- OSA: a fast and accurate alignment tool for RNA-SeqBioinformatics, 2012
- Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver FibrosisPLOS ONE, 2011
- Diverse evolutionary paths to cell adhesionTrends in Cell Biology, 2010
- Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equalExpert Review of Gastroenterology & Hepatology, 2009
- Cellular Sources of Extracellular Matrix in Hepatic FibrosisClinics in Liver Disease, 2008
- Serum Intercellular Adhesion Molecule‐1 in Patients With Nonalcoholic Steatohepatitis: Comparison With Alcoholic HepatitisAlcohol: Clinical and Experimental Research, 2007
- Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in miceJournal of Hepatology, 2004
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003